David Pezeshki
Venbio Partners Llc
Assets Managed
$280.553M
Holdings
6
Last Quarter
2026 - Q1
Filed Date
17d ago
Growth Rate
29.73%(2Q avg: 26.17%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Venbio Partners Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 6 positions.
Assets under management
The assets under management (AUM) of Venbio Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 280.553M in assets, with a quarterly growth rate of 29.73% and a 2-quarter average growth rate of 26.17%. The portfolio is managed by David Pezeshki, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
PHVS Pharvaris Nv
| 46.72% | $131.06M 4.639M shares@ $28.25 avg price | |
ALMS Alumis Inc
| 35.56% | $99.761M 4.528M shares@ $22.03 avg price | Decreased -1.97% |
ALXO Alx Oncology Holdings Inc
| 9.21% | $25.834M 12.885M shares@ $2.01 avg price | Increased 32.84% |
HRMY Harmony Biosciences Holdings
| 4.89% | $13.702M 489,194 shares@ $28.02 avg price | |
LYEL Lyell Immunopharma Inc
| 2.42% | $6.774M 337,697 shares@ $20.07 avg price | |
ARTV Artiva Biotherapeutics Inc
| 1.22% | $3.422M 531,337 shares@ $6.44 avg price | Decreased -18.06% |
1-6 of 6